Dermatophytic defensin with antiinfective potential

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 22, 2012, Pages 8495-8500

  Zhu, Shunyi ^a   Gao, Bin ^a   Harvey, Peta J ^b   Craik, David J ^b  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ascomycota; Methicillin resistant Staphylococcus aureus; Mouse peritonitis model; Plectasin

Indexed keywords

ANTIINFECTIVE AGENT; CYSTEINE; DEFENSIN; MICASIN; PLECTASIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; DERMATOPHYTE; DRUG MECHANISM; DRUG STABILITY; FUNGAL GENOME; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OPPORTUNISTIC INFECTION; PERITONITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SURVIVAL;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFECTIVE AGENTS; ARTHRODERMATACEAE; BASE SEQUENCE; CLONING, MOLECULAR; DEFENSINS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FUNGAL PROTEINS; HEMOLYSIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED ICR; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PERITONITIS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID;

ASCOMYCOTA; FUNGI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; POSIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 84861839472     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1201263109     Document Type: Article

References (30)

1. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
2. Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-350.
3. Hale JD, Hancock RE (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti Infect Ther 5:951-959. (Pubitemid 350303026)
4. Srinivas N, et al. (2010) Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science 327:1010-1013.
5. Easton DM, Nijnik A, Mayer ML, Hancock RE (2009) Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol 27:582-590.
6. Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529-536. (Pubitemid 43905612)
7. Vaara M (2009) New approaches in peptide antibiotics. Curr Opin Pharmacol 9:571-576.
8. Marr AK, Gooderham WJ, Hancock RE (2006) Antibacterial peptides for therapeutic use: obstacles and realistic outlook. Curr Opin Pharmacol 6:468-472. (Pubitemid 44340665)
9. Eckert R (2011) Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol 6:635-651.
10. Mygind PH, et al. (2005) Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975-980. (Pubitemid 41486973)
11. Hara S, et al. (2008) Plectasin has antibacterial activity and no affect on cell viability or IL-8 production. Biochem Biophys Res Commun 374:709-713.
12. Zhu S (2008) Discovery of six families of fungal defensin-like peptides provides insights into origin and evolution of the CSαβ defensins. Mol Immunol 45:828-838.
13. Wang Y, Zhu S (2011) The defensin gene family expansion in the tick Ixodes scapularis. Dev Comp Immunol 35:1128-1134.
14. Gao B, Zhu L, Zhu S (2011) A naturally-occurring carboxyl-terminally truncated alpha-scorpion toxin is a blocker of sodium channels. Biochem Biophys Res Commun 411:673-678.
15. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J Biomol NMR 5:67-81.
16. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477-486. (Pubitemid 126706801)
17. Hutchinson EG, Thornton JM (1996) PROMOTIF-a program to identify and analyze structural motifs in proteins. Protein Sci 5:212-220. (Pubitemid 26054277)
18. Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F (2008) Rational design of peptides active against the gram positive bacteria Staphylococcus aureus. Proteins 72:229-239. (Pubitemid 351809161)
19. Yeaman MR, Yount NY (2007) Unifying themes in host defence effector polypeptides. Nat Rev Microbiol 5:727-740. (Pubitemid 47278866)
20. Gao B, Sherman P, Luo L, Bowie J, Zhu S (2009) Structural and functional characterization of two genetically related meucin peptides highlights evolutionary divergence and convergence in antimicrobial peptides. FASEB J 23:1230-1245.
21. Schneider T, et al. (2010) Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II. Science 328:1168-1172.
22. van der Weerden NL, Hancock RE, Anderson MA (2010) Permeabilization of fungal hyphae by the plant defensin NaD1 occurs through a cell wall-dependent process. J Biol Chem 285:37513-37520.
23. Fleming A (1929) On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenza. Br J Exp Pathol 10:226-236.
24. Coates A, Hu Y, Bax R, Page C (2002) The future challenges facing the development of new antimicrobial drugs. Nat Rev Drug Discov 1:895-910. (Pubitemid 37361584)
25. Coates A, Halls G, Hu Y (2011) Novel classes of antibiotics or more of the same? Br J Pharmacol 163:184-194.
26. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new antiinfective therapeutic strategies. Nat Biotechnol 24:1551-1557. (Pubitemid 44967479)
27. Kirk PM, Cannon PF, David JC, Stalpers JA (2010) Ainsworth and Bisby's dictionary of the Fungi (CAB International, Wallingford, UK), 9th Ed.
28. Cogen AL, Nizet V, Gallo RL (2008) Skin microbiota: a source of disease or defence? Br J Dermatol 158:442-455. (Pubitemid 351239198)
29. Cogen AL, et al. (2010) Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin. J Invest Dermatol 130:192-200.
30. Hainer BL (2003) Dermatophyte infections. Am Fam Physician 67:101-108.